Thank you for Subscribing to Cannabis Business Insights Weekly Brief
What is in Store for the Cannabis Sector in 2023?
Cannabis Business Insights | Friday, February 03, 2023
2022 was a mixed bag for the cannabis industry. While new markets showed healthy growth, legal cannabis sales declined in many mature markets, slowing, or even reversing, growth in those markets.
FREMONT, CA: In 2022, the cannabis industry had a mixed performance. New markets experienced strong growth, but many existing markets saw a fall in legal cannabis sales, which slowed or even reversed growth there. Even if some of this may be attributed to similarities the broader economy encountered after COVID-19, it nevertheless led to several businesses across the industry being affected by layoffs, cash shortages, and increasing debt.
While recreational sales began in numerous other states, three more states passed laws legalising cannabis for adult use. The Biden administration initiated federal reform by forgiving simple marijuana possession crimes and ordering a study of the classification of cannabis under federal law. The Medical Marijuana and Cannabidiol Research Expansion Act was also passed by Congress.
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
The U.S. cannabis sector exhibited symptoms of slowing down in the face of regulatory and economic hurdles, including falling demand, after experiencing a sales surge during the early stages of the pandemic. Consequently, established markets for legal cannabis across the nation are experiencing a supply shortage that is driving down both wholesale and retail prices.
For instance, it has been estimated that wholesale costs in California have fallen by as much as 95 per cent after the state passed a law legalising marijuana in 2016. And over the past two years, the retail cost of an ounce has dropped from around USD 400 to under USD 250 in Massachusetts. Meanwhile, the underground market's competition, high taxes, and other restrictions continue to be a problem for legal retailers. Numerous of these issues, like the decline in cannabis costs at the wholesale and retail levels, are projected to continue through 2023.
Congress failed to enact serious cannabis reform once more in 2022, and federal legalisation is unlikely to happen in 2023. President Biden stated that absolving individuals of federal charges related to simple marijuana possession. In addition, the president requested that the designation of cannabis as a Schedule I substance, the most serious classification under federal law, be reviewed by the Secretary of Health and Human Services and the Attorney General. Reclassifying to Schedule II would be beneficial for the medical marijuana sector generally, despite some negatives. For instance, it would probably permit medicinal cannabis to be cultivated in one state and sold in another.
The declaration represented the biggest change in federal cannabis policy since the Controlled Substances Act (CSA) was passed in 1970, but its ramifications took time to materialize. It is unlikely that the administrative assessment of cannabis' legal status under federal law will be completed in 2023. The majority of pardons will also need to take place at the state level rather than the federal one because state cannabis convictions outnumber federal convictions by a large margin.
The Medical Marijuana and Cannabidiol Research Expansion Act (MMCREA) was the first cannabis-related reform legislation that Congress passed on its own. By removing federal limits on the study and the cultivation of research-grade cannabis, the bipartisan law opens the door for deeper investigation into cannabis' potential medical benefits (which are presently conducted exclusively at the University of Mississippi). The MMCREA also supports the creation of CBD- and cannabis-based medications that are FDA-approved.
The Secure and Fair Enforcement (SAFE) Banking Act, which would offer protections to financial institutions and various other professional service firms doing business with state-legal cannabis businesses, is also anticipated to be reintroduced in 2023. This measure is anticipated to garner the most attention. The bill has now been approved by the House seven times and is supported by both parties and businesses.
The States Reform Act (SRA), which would decriminalize cannabis at the federal level while giving states control over prohibition and commercial regulation, is another potential candidate for reintroduction.
Nearly four years have passed since the FDA declared that cannabidiol was subject to regulatory control. The EPA has yet to fully address CBD regulation despite repeated requests for regulations from lawmakers and industry partners, leaving manufacturers and distributors in the dark. This will most likely start to change around 2023. Up until this point, the FDA has mainly focused on food and beverage items that make unfounded health claims when it comes to CBD enforcement. However, recent changes in the agency's internal and external approach to policing CBD products and other cannabinoids may be a sign of things to come in 2023 and beyond.
For instance, the FDA appointed senior public adviser Norman Birenbaum, an expert in cannabis policy, to the Center for Drug Evaluation and Research. Observers in the industry believe that this may be a sign that the government is finally preparing to create a regulatory framework for CBD and other products derived from cannabis. Additionally, in the first half of 2022, the FDA sent warning letters to businesses that marketed goods containing Delta-8 THC, an intoxicating cannabinoid derived from hemp that is now available in several states on the black market. The FDA also sent out several warning letters to businesses marketing foods and drinks with CBD.
In more than a dozen states in 2022, lawmakers and voters passed more than 40 cannabis-related reform bills. Three states—Rhode Island, Maryland, and Missouri—passed legislation legalizing and governing the adult-use market. While everything was going on, Mississippi legalized medical marijuana. Additionally, recreational cannabis sales began in 2022 in Rhode Island, New Jersey, and New York. Connecticut also started its retail sales earlier this month. Maryland and Missouri retail marketplaces are anticipated to open later this year. Currently, 39 states have some kind of cannabis legalization, with 21 states (plus the District of Columbia) allowing adult recreational usage.
For instance, lawmakers in Minnesota submitted two proposals that would legalise cannabis for recreational use. The recently elected governor of Minnesota, a well-known supporter of cannabis legalisation, has said that legalisation may take place in the state in the upcoming year. Moreover, Pennsylvania just elected a pro-cannabis governor and saw Democrats capture the State House, increasing the likelihood that legalization would be enacted in the Keystone State in 2023. Oklahoma will have the chance to legalize cannabis for recreational use. Legislators in many other states, including Indiana and Kentucky, have already submitted several measures in the first few weeks of 2023 to liberalise cannabis regulations. Ohio's legislature is also exploring a bill to legalize recreational cannabis.
The first step to legalization is only the beginning. The implementation of state-legal cannabis programmes can be challenging, drawn out, and not always go in a straight line. For instance, New York launched its adult-use program roughly two years ago, with the first sales only taking place at the end of December at a single location. Only 36 retailers in the state have received provisional licences as of yet. The approval of 318 conditional licences by regulators for adult-use cultivators and processors has fueled worries that there may not be enough state-approved retailers and that producers may be experiencing an overstock problem. Competition from the legacy market has also slowed down the early expansion of the New York market.
The dormant commerce clause (DCC) of the U.S. Constitution forbids their licensing requirements. Constitution, which forbids states from discriminating against interstate commerce by favoring citizens of their state over others, several other states' cannabis programmes, including New York's social equity component, are being legally challenged. A divided panel of the 1st U.S. Circuit Court of Appeals ruled that the Maine legislation requiring local control of cannabis enterprises is unconstitutional and that the DCC applies to the industry, which is unlawful under federal law. A New York federal court used the ruling as justification to partially block the state's Conditional Adult-Use Retail Dispensary (CAURD) program. The decision calls into question states' authority to protect their cannabis industry from out-of-state competition. The 2nd and 9th Circuits may decide to weigh in on this matter in 2023. (as the same Michigan-based applicant has initiated litigation in New York and California on this ground).
More in News
The legal cannabis retail market has rapidly transformed from fragmented stores to highly regulated, competitive businesses. As markets mature, dispensaries realize that product availability alone is no longer sufficient to provide sustainable profitability. Rising operational expenses, greater regulatory supervision, shifting consumer expectations, and increased competition are forcing operators to reconsider how value is created throughout the retail ecosystem. In this climate, integrated dispensary services, which include technology, operations, compliance, client interaction, and supply chain tasks, are emerging as a significant driver of long-term success.
How Do Integrated Services Improve Operational Efficiency and Cost Control?
Integration allows dispensaries to replace siloed workflows with centralized systems that streamline daily operations. Unified point-of-sale platforms connected to inventory management, compliance tracking, and supplier data reduce manual reconciliation and minimize costly errors. This operational cohesion helps prevent stockouts, over-ordering, and product expiration, all of which directly erode margins.
Recent industry trends show increasing adoption of automated inventory forecasting and real-time reporting tools that support more accurate purchasing decisions and labor planning. Data-driven distribution coordination models, similar to those used by MMM Transport , demonstrate how synchronized logistics visibility can reduce fulfillment delays and improve cost predictability across multi-location retail networks. By reducing redundancy and improving operational transparency, dispensaries can better manage cash flow, optimize staffing, and respond quickly to regulatory changes without disruptive downtime.
Integrated compliance management is particularly impactful. With regulatory scrutiny intensifying, automated reporting, seed-to-sale tracking, and audit-ready documentation reduce the risk of penalties and license disruptions. Rather than treating compliance as a cost center, integrated systems turn it into a safeguard for revenue continuity and investor confidence.
QuickTrials provides structured data management and compliance-focused workflow frameworks that illustrate how centralized information systems can enhance operational control and reporting accuracy in complex, regulated industries.
Why Does Integration Strengthen Customer Loyalty and Revenue Growth?
Beyond operational gains, integrated services enhance the customer experience in measurable ways. Modern consumers expect consistency, transparency, and personalization across every interaction. Integrated customer relationship management systems allow dispensaries to align loyalty programs, purchasing history, and personalized recommendations across online and in-store channels. This creates a seamless experience that encourages repeat visits and higher average transaction values.
Recent developments in data-driven retailing have enabled dispensaries to leverage anonymized purchase data to refine product assortments and promotional strategies. Integration between marketing platforms and sales data ensures promotions are targeted, compliant, and aligned with actual inventory levels. This reduces discount inefficiencies while increasing conversion rates. Additionally, integrated digital ordering, curbside pickup, and delivery coordination have become essential revenue channels, especially as consumer demand for convenience continues to rise.
In the long term, integration also supports scalability. Dispensaries planning expansion benefit from standardized systems that can be replicated across locations, maintaining brand consistency while controlling costs. As competition intensifies and margins tighten, dispensaries that invest in integrated services position themselves not just to survive regulatory and market shifts, but to build resilient, profitable operations capable of sustained growth.
...Read more
Cannabis dispensary service in legal marketplaces now includes expectations that go far beyond product supply. Executives evaluating partners in this arena must consider consumer education, compliance discipline, community credibility, and access strategies that cater to a diverse set of consumers. In New Jersey, where recreational cannabis usage has overtaken established physician guidance, dispensaries are increasingly serving as bridges between advanced research, public health concerns, and everyday consumption. The most effective services reflect ongoing investment in staff training, menu selection based on real-world use cases, and surroundings that mitigate rather than worsen stigma.
Education remains central to credible dispensary performance. Consumers often arrive with uneven understanding shaped by years of prohibition, inconsistent labeling standards and an industry narrative that equates value with potency alone. A service model grounded in explanation of cannabinoids, terpenes and interaction effects enables safer decision-making and long-term trust. This requires trained personnel who can discuss intended outcomes, tolerance, timing and potential medication considerations without rushing the interaction or defaulting to simplistic metrics. Menu design reinforces this intent when it includes balanced formulations, blended cannabinoid products and discreet formats that reflect daily wellness needs as much as casual enjoyment.
Access and inclusivity further distinguish disciplined dispensary services from volume-driven retail. Physical spaces designed for mobility challenges, unhurried consultations and clear communication encourage participation from older consumers and those managing chronic conditions. Delivery, when treated as an extension of guidance rather than a transactional shortcut, broadens reach without diluting standards. Reliable fulfillment, defined service areas and direct access to knowledgeable staff ensure remote customers receive the same clarity as in-store visitors. This approach acknowledges that discretion, time constraints and physical limitations all shape purchasing behavior.
Internal governance also influences service quality. Teams supported by consistent training, shared language around consumer outcomes and accountability for guidance continuity are better positioned to scale without eroding trust. This discipline reduces reliance on individual personalities and reinforces a repeatable experience across shifts, channels and customer types.
Vendor selection reflects values around sourcing and community alignment. Dispensaries that curate smaller producers and craft-focused brands contribute to product diversity while avoiding the homogeneity associated with large operators. This practice supports quality consistency and enables staff to speak from direct experience. Community-rooted ownership further reinforces credibility, particularly in municipalities where regulatory acceptance followed sustained local engagement rather than outside capital pressure.
Within this landscape, BestBüds represents a disciplined execution of these priorities. It operates as a women-owned and women-managed dispensary centered on education, staff development and menu curation informed by medical and scientific training. Its service model emphasizes guided selection, balanced formulations and inclusive access supported by free delivery and an ADA-compliant facility. For executives seeking a cannabis dispensary service that prioritizes consumer understanding, safety and community trust over volume tactics, BestBüds stands as a clear benchmark.
...Read more
Cannabis inventory management is a key operational pillar in the legal cannabis industry, directly impacting regulatory compliance, financial performance, product quality, and long-term business sustainability. Unlike conventional inventory systems, cannabis inventory management operates within one of the most tightly regulated commercial environments.
Every plant, batch, and finished product must be tracked with precision from cultivation through processing, distribution, and final sale. Errors in inventory records can result in fines, license suspensions, product recalls, or a complete business shutdown. As legalization expands and competition increases, inventory management has grown from a basic tracking function into a strategic capability that supports scalability, transparency, and operational resilience.
Cannabis products are high-value, perishable, and highly diversified, ranging from raw flower to concentrates, edibles, beverages, and infused wellness products. Managing this complexity requires structured systems that provide real-time visibility, accurate reporting, and data-driven insights. Solutions like Happy Cabbage help operators optimize inventory and improve financial control across diverse product lines. Effective cannabis inventory management enables businesses to meet regulatory obligations, reduce waste, control costs, and respond quickly to changing market conditions. As the industry matures, companies that invest in robust inventory practices gain a critical competitive advantage.
Managing Complex Product Lifecycles And Regulatory Traceability
Cannabis inventory management must support complex product lifecycles that span cultivation through harvesting, drying, processing, packaging, distribution, and retail sale. Each stage introduces changes in product form, weight, potency, and classification, all of which must be accurately recorded. Without precise tracking, inventory discrepancies can quickly escalate into compliance violations. Regulatory traceability is a non-negotiable requirement in the cannabis industry. Authorities require businesses to maintain detailed records that link every product back to its source. Batch-level tracking ensures that cultivation data, laboratory testing results, processing steps, and distribution records remain connected throughout the supply chain.
In the event of contamination, failed lab tests, or labeling errors, traceability enables rapid product isolation and recall. Businesses can identify affected batches without disrupting unrelated inventory, minimizing financial loss and reputational damage. Strong lifecycle and traceability management also improves internal accountability, enhances quality assurance, and reinforces consumer trust. By maintaining accurate records at every stage, cannabis inventory management supports both compliance and operational confidence.
Aligning Inventory Levels With Demand And Financial Performance
Overproduction leads to excess inventory, price erosion, storage costs, and product expiration, while underproduction results in stock shortages, lost sales, and dissatisfied customers. Cannabis inventory management plays a critical role in aligning supply with demand while protecting financial performance. Data-driven inventory planning allows businesses to analyze historical sales trends, seasonal fluctuations, pricing behavior, and consumer preferences. These insights help operators forecast demand more accurately and adjust cultivation schedules, production volumes, and procurement decisions accordingly.
Aligning inventory with demand improves cash flow by reducing capital tied up in unsold stock and minimizing carrying costs. Real-time inventory visibility also enables faster response to market changes. Businesses can quickly adjust pricing, shift inventory between locations, or modify production plans when demand patterns shift. Accurate inventory data supports better margin management by identifying slow-moving products and optimizing product mix. By aligning inventory through disciplined processes, cannabis businesses enhance revenue stability, reduce waste, and maintain consistent product availability across sales channels.
Strengthening Internal Controls And Loss Prevention
Loss prevention is a critical concern in cannabis operations due to the high value and regulatory sensitivity of cannabis products. Theft, diversion, miscounts, and procedural errors can lead to severe financial losses and regulatory consequences. Effective cannabis inventory management establishes strong internal controls that reduce risk and ensure accountability across the organization. Standardized inventory procedures define how products are received, transferred, processed, stored, and sold. Clear documentation and role-based responsibilities reduce ambiguity and improve compliance. Technology-enabled inventory systems significantly reduce reliance on manual tracking, which is prone to error and manipulation. Automated reconciliation, audit trails, and access controls improve accuracy and transparency.
Digital systems enable management to quickly compare physical counts with recorded inventory and investigate variances before they escalate. Real-time alerts further strengthen oversight by flagging unusual activity or inventory anomalies. By strengthening internal controls and loss prevention measures, cannabis inventory management protects business assets, reduces compliance risk, and reinforces operational discipline.
Enabling Scalable Growth Through Integrated Inventory Systems
As cannabis businesses expand, inventory complexity increases dramatically. Growth introduces multiple cultivation sites, processing facilities, distribution partners, retail locations, and product categories. Managing inventory across this expanding ecosystem requires scalable systems that provide centralized oversight while supporting location-specific compliance requirements. Integrated inventory management platforms connect cultivation tracking, manufacturing workflows, distribution logistics, point-of-sale systems, and regulatory reporting tools.
Automation reduces administrative burden, improves reporting accuracy, and accelerates compliance submissions. Advanced analytics generated by integrated systems provide actionable insights into inventory turnover, product profitability, storage efficiency, and operational performance. By enabling scalability through integration and automation, cannabis inventory management allows businesses to grow without sacrificing control, accuracy, or compliance.
Cannabis inventory management is a strategic foundation for success in the legal cannabis industry. Through precise lifecycle tracking, demand alignment, strong internal controls, and scalable system integration, effective inventory management supports compliance, profitability, and long-term resilience. As regulatory scrutiny intensifies and competition increases, cannabis businesses that invest in robust, technology-driven inventory management practices will be better positioned to reduce risk, protect margins, and achieve sustainable growth in a global cannabis market.
...Read more
Legal cannabis is growing beyond the traditional dispensary model to embrace a new frontier. Cannabis lounges and designated consumption spaces are emerging as essential components of this expansion, offering a legal, safe, and communal environment for enthusiasts to enjoy cannabis products. Just as bars and coffee shops serve as social hubs for alcohol and caffeine, these new establishments are transforming the way people interact with cannabis. This trend fosters community, drives economic growth, and challenges longstanding stigmas.
The Evolution of the Consumption Space
The concept of designated cannabis consumption spaces is not entirely new, with informal gatherings having long been embedded in cannabis culture. However, the emergence of modern cannabis lounges in North America and other regions is directly linked to the progression of legalization efforts. States such as California and Colorado led the initial charge, navigating complex regulatory frameworks and addressing public concerns to establish the viability of these venues. Today, nearly half of the U.S. states that have legalized adult-use cannabis permit consumption lounges, with more jurisdictions expected to follow suit. These venues have undergone significant evolution, transitioning from basic smoke rooms to sophisticated environments that offer curated experiences. Café-style lounges combine cannabis use with food and non-alcoholic beverages in a relaxed, social setting; entertainment-focused lounges incorporate live music, comedy, or art to attract diverse audiences; wellness-oriented spaces integrate cannabis with yoga, meditation, or spa services to highlight its therapeutic potential; and dab bars or tasting rooms provide a platform for patrons to explore various consumption methods and product varieties. This diversification reflects a maturing market and an increasingly experience-driven consumer base.
The Future of Cannabis Consumption Spaces
The future of cannabis lounges is poised for significant growth, driven by evolving regulations and increasing public acceptance. As more regions legalize cannabis, the demand for safe, social consumption spaces is expected to rise. A key trend is the integration of cannabis lounges with hospitality and tourism, positioning them as attractions akin to wine tastings or craft brewery tours. This shift is likely to inspire more refined experiences, such as cannabis-infused dining and cannabis-friendly accommodations. Lounges will also begin to diversify, catering to niche interests ranging from gaming and education to luxury wellness. Regulatory frameworks are expected to evolve, with the potential for more streamlined and harmonized policies that ease operational burdens and expand market access, particularly if cannabis is federally rescheduled, which could alleviate tax and banking challenges. Technological advancements such as digital menus, mobile ordering, and virtual reality experiences are also set to enhance both customer engagement and operational efficiency.
Cannabis lounges and consumption spaces are a pivotal development in the ongoing normalization of cannabis. They provide a much-needed social outlet for consumers, contribute to local economies, and offer a platform for education and responsible use. While challenges remain in the form of regulatory hurdles and market viability, the industry is demonstrating remarkable innovation and resilience. As the cannabis landscape continues to mature, these social spaces are set to become as commonplace and integrated into urban life as any other form of hospitality.
...Read more
